0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      P21 (Cdc42/Rac)-activated kinase 1 (pak1) is associated with cardiotoxicity induced by antihistamines.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Astemizole, a non-sedating histamine H1 receptor blocker, is widely known to cause cardiac arrhythmia, which prolongs the QT interval. However, the precise molecular mechanism involved in antihistamine-induced cardiovascular adverse effects other than hERG channel inhibition is still unclear. In this study, we used DNA microarray analysis to detect the mechanisms involved in life-threatening adverse effects caused by astemizole. Rat primary cardiomyocytes were treated with various concentrations of astemizole for 24 h and the corresponding cell lysates were analyzed using a DNA microarray. Astemizole altered the expression profiles of genes involved in calcium transport/signaling. Using qRT-PCR analysis, we demonstrated that, among those genes, p21 (Cdc42/Rac)-activated kinase 1 (pak1) mRNA was downregulated by treatment with terfenadine and astemizole. Astemizole also reduced pak1 protein levels in rat cardiomyocytes. In addition, astemizole decreased pak1 mRNA and protein levels in H9c2 cells and induced an increase in cell surface area (hypertrophy) and cytotoxicity. Fingolimod hydrochloride (FTY720), a pak1 activator, inhibited astemizole-induced hypertrophy and cytotoxicity in H9c2 cells. These results suggest that antihistamine-induced cardiac adverse effects are associated with pak1 expression and function.

          Related collections

          Author and article information

          Journal
          Arch Pharm Res
          Archives of pharmacal research
          Springer Science and Business Media LLC
          0253-6269
          0253-6269
          Dec 2016
          : 39
          : 12
          Affiliations
          [1 ] Pharmacological Research Division, National Institute of Drug and Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 363-700, Republic of Korea. actpotyjs@korea.kr.
          [2 ] Pharmacological Research Division, National Institute of Drug and Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 363-700, Republic of Korea.
          [3 ] Pharmacological Research Division, National Institute of Drug and Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, 363-700, Republic of Korea. kimhs58@korea.kr.
          Article
          10.1007/s12272-016-0840-7
          10.1007/s12272-016-0840-7
          27681411
          8c2cf09c-d5f5-430a-9f3f-a5e2244039fd

          Antihistamine,Astemizole,Cardiotoxicity,Genomics
          Antihistamine, Astemizole, Cardiotoxicity, Genomics

          Comments

          Comment on this article